Drug Patent List
First Filer Exclusivity TimelineNew
Newsletter
Weekly Digest

Pharsight

Columbia Drug Patent Portfolio

Columbia's Family Patents


Family Patents





Clinical Trials

Recent Clinical Trials by Columbia:

Title Lead Sponsor Collaborators Status Phases
Clinical Trials
Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma Columbia University NA ACTIVE NOT RECRUITING
(Sep 1, 2026)
PHASE2
Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments University of British Columbia NA RECRUITING
(Sep 1, 2026)
PHASE2, PHASE3
Graded Insulin Suppression Test P&F Columbia University NA RECRUITING
(Sep 1, 2026)
PHASE1
Alpelisib Challenge Test (ACT) Columbia University NA RECRUITING
(Sep 1, 2026)
PHASE1
Post-Vasectomy Pain Study Columbia University NA RECRUITING
(Sep 1, 2026)
PHASE1
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H) Columbia University NA COMPLETED
(Aug 1, 2026)
PHASE3
Evaluation of Progression of Myopia in Children Treated With Vitamin B2 and Outdoor Sunlight Exposure University of Missouri-Columbia NA WITHDRAWN
(Aug 1, 2026)
PHASE2
Human Models of Selective Insulin Resistance: Alpelisib, Part I Columbia University NA RECRUITING
(Aug 1, 2026)
PHASE1
Diazoxide Suppression Test P&F Study Columbia University NA TERMINATED
(Aug 1, 2026)
PHASE1
SWITCH: Apixaban vs Vitamin K in HM3 Columbia University NA NOT YET RECRUITING
(Aug 1, 2026)
PHASE3
Topical TOR-582 Treatment of Epistaxis in HHT Columbia University NA NOT YET RECRUITING
(Aug 1, 2026)
PHASE1
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer University of British Columbia NA RECRUITING
(Jul 1, 2026)
PHASE2
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis Columbia University NA ACTIVE NOT RECRUITING
(Jul 1, 2026)
PHASE1, PHASE2
Effect of Insulin Lowering on Lipogenesis Columbia University NA RECRUITING
(Jul 1, 2026)
PHASE1
Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy Columbia University NA NOT YET RECRUITING
(Jul 1, 2026)
PHASE3
Effects of Sirolimus on Asymptomatic ApoE4 Carriers University of Missouri-Columbia NA NOT YET RECRUITING
(Jul 1, 2026)
PHASE1
R-MVST Cells for Treatment of Viral Infections Columbia University NA RECRUITING
(Jun 1, 2026)
PHASE1
Siplizumab for Sickle Cell Disease Transplant Columbia University NA TERMINATED
(Jun 1, 2026)
PHASE1, PHASE2
131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD) Columbia University NA RECRUITING
(Jun 1, 2026)
PHASE1
Tranexamic Acid to Reduce Blood Loss in Spine Surgery Columbia University NA RECRUITING
(May 1, 2026)
PHASE2, PHASE3
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma Columbia University NA ACTIVE NOT RECRUITING
(May 1, 2026)
PHASE2
Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease University of British Columbia NA RECRUITING
(May 1, 2026)
PHASE2
Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes Columbia University NA TERMINATED
(Apr 1, 2026)
PHASE3
Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer British Columbia Cancer Agency NA RECRUITING
(Apr 1, 2026)
PHASE2
Oral Steroid Taper After Total Knee Arthroplasty Columbia University NA ACTIVE NOT RECRUITING
(Apr 1, 2026)
PHASE1
Safely Quenching Complement in Stroke Survivors Columbia University NA NOT YET RECRUITING
(Apr 1, 2026)
PHASE1
Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI University of British Columbia Bristol-Myers Squibb COMPLETED
(May, 2016)


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List